Zealthy Expands Insurance Coordination for GLP-1 Weight-Loss Medications

In this episode of Global Economic Press, Alex Brady discusses the recent expansion of Zealthy's insurance-coordination program for GLP-1 weight-loss medications. Zealthy, a prominent online healthcare platform, aims to streamline the insurance process for patients seeking coverage for medications such as Wegovy, Zepbound, Ozempic, and Mounjaro. The expansion involves a comprehensive approach where Zealthy's care coordination team collaborates with patients, healthcare providers, pharmacies, and insurance companies to facilitate insurance verification, prior-authorization submissions, and coverage determinations. This initiative is designed to create a more structured process for submitting required documentation and keeping patients informed about their coverage requests. Zealthy's expanded program includes various services such as verification of pharmacy benefits, review of plan-specific coverage requirements, and support in evaluating options following a denial. Patients begin the process by completing a medical assessment on Zealthy's online platform, which is reviewed by a licensed provider to determine the appropriate treatment. The program emphasizes that insurance companies retain full authority over approval decisions and patient costs, and Zealthy's team does not guarantee approval. The virtual weight-management program also offers provider messaging, prescription management, and follow-up care. For more information about Zealthy and its services, visit GetZealthy.com.